20/20 Biolabs, Inc. Common Stock share price logo

20/20 Biolabs, Inc. Common Stock Share Price

NASDAQ: AIDX

Small Cap

$1.78

+0.06

(+3.49%)

as on

20/20 Biolabs, Inc. Common Stock Stock Performance

as on April 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.69
    $1.85
    downward going graph

    5.06%

    Downside

    3.93%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

20/20 Biolabs, Inc. Common Stock share price movements today

Previous Close
$1.72
Open
$1.74
Volume
292.4K
Day's Low - High
$1.69 - $1.85

20/20 Biolabs, Inc. Common Stock Historical Returns

1 Month Return
-20.37 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

20/20 Biolabs, Inc. Common Stock Stock Fundamentals & Key Indicators

Check 20/20 Biolabs, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.2M

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-503.12%

20/20 Biolabs, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of 20/20 Biolabs, Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
20/20 Biolabs, Inc. Common Stock image
20/20 Biolabs, Inc. Common Stock
NA$18.2MNANA-182.82%
Boston Scientific Corp image
Boston Scientific Corp
BUY$94.3B55.02%32.6914.44%
Stryker Corporation image
Stryker Corporation
BUY$129.6B31.6%40.3312.92%
Medtronic PLC image
Medtronic PLC
BUY$110.0B-31.98%23.9213.00%
Edwards Lifesciences Corp image
Edwards Lifesciences Corp
BUY$45.9B-11.2%43.6717.69%
See all

20/20 Biolabs, Inc. Common Stock Stock’s Investor Sentiment and Interest

Search interest for 20/20 Biolabs, Inc. Common Stock Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

20/20 Biolabs, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2024
Dec 2024
Sep 2025
Dec 2025
Total Revenue
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
Operating Income
-1
-1
-1
-1
0
0
EBITDA
-1
-1
-1
-1
0
-
Interest Expense
0
0
-
-
0
0
Depreciation
-
-
-
0
-
0
Income Before Tax
-1
-1
-1
-1
0
-1
Income Tax Expense
-
-
-
-
-
-
Net Income
-1
-1
-1
-1
0
-1
Net Profit Margin
-475.66%
-511.03%
-518.97%
-232.99%
-197.51%
-242.96%

20/20 Biolabs, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
2
9
11
1
1
2,045
Gross Profit
0
0
0
0
0
4
5
0
0
604
Operating Income
-2
-1
-1
-2
-2
1
1
-6
-5
-3,330
EBITDA
-2
-1
-1
-2
-1
2
1
-6
-5
-3,330
Interest Expense
0
-
-
-
-
0
0
0
0
-156
Depreciation
-
-
-
-
-
-
-
0
0
0
Income Before Tax
-2
-1
-1
-2
-2
2
2
-6
-5
-3,738
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-2
-1
-1
-2
-2
2
2
-6
-5
-3,738
Net Profit Margin
-521.79%
-403.63%
-528.11%
-841.25%
-86.75%
21.53%
19.77%
-448.73%
-316.81%
-182.82%

20/20 Biolabs, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Dec 2024
Dec 2025
Net Income
-1
-1
-1
Operating Cash Flow
-1
0
0
Investing Cash Flow
0
-
-
Financing Cash Flow
0
0
0
Change in Cash
-1
1
0

20/20 Biolabs, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-1
-2
-2
2
2
-6
-5
-3,738
Operating Cash Flow
-1
-1
-2
-2
-1
5
-4
-2
-1,919
Investing Cash Flow
0
0
-1
1
0
0
0
-
-
Financing Cash Flow
1
3
1
3
1
0
0
0
1,161
Change in Cash
0
2
-2
2
0
5
-4
-2
-758

Insights on 20/20 Biolabs, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AIDX stock has moved down by -8.5%

About 20/20 Biolabs, Inc. Common Stock

20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Organisation20/20 Biolabs, Inc. Common Stock
Headquarters15810 Gaither Road, Gaithersburg, MD, United States, 20877
IndustryMedical Devices
CEOMr. Jonathan Cohen
E-voting on sharesClick here to vote

Key Management of 20/20 Biolabs, Inc. Common Stock

Name

Title

Dr. Michael Saul Lebowitz Ph.D.

Chief Scientific Officer

Mr. Alan B. Bergman

Chief Financial Officer

Mr. David Lees

Director of Sales

Mr. Ronald R. Baker

Chief Business Officer

Marc Gordon

Controller

Mr. Jonathan Cohen

Founder, CEO, President & Director

Dr. Jiming Zhou Ph.D.

Chief Operating Officer

FAQs

What is 20/20 Biolabs, Inc. Common Stock share price today?

20/20 Biolabs, Inc. Common Stock share price today is $1.78 as on at the close of the market. 20/20 Biolabs, Inc. Common Stock share today touched a day high of $1.85 and a low of $1.69.

What is the 52 week high and 52 week low for 20/20 Biolabs, Inc. Common Stock share?

20/20 Biolabs, Inc. Common Stock share touched a 52 week high of $ on and a 52 week low of $ on . 20/20 Biolabs, Inc. Common Stock stock price today i.e. is closed at $1.78,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is 20/20 Biolabs, Inc. Common Stock's market capitalisation today?

20/20 Biolabs, Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in 20/20 Biolabs, Inc. Common Stock Stock (AIDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for 20/20 Biolabs, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 20/20 Biolabs, Inc. Common Stock Shares that will get you 0.8427 shares as per 20/20 Biolabs, Inc. Common Stock share price of $1.78 per share as on April 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy 20/20 Biolabs, Inc. Common Stock Stock (AIDX) from India?

Indian investors can start investing in 20/20 Biolabs, Inc. Common Stock (AIDX) shares with as little as ₹92.768 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹927.68 in 20/20 Biolabs, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on 20/20 Biolabs, Inc. Common Stock share’s latest price of $1.78 as on April 18, 2026 at 1:29 am IST, you will get 5.6180 shares of 20/20 Biolabs, Inc. Common Stock. Learn more about fractional shares .